Literature DB >> 32721092

Operational tolerance in intestinal transplantation.

Alexander Kroemer1, Khalid Khan1, Stuart S Kaufman1, Jiman Kang1, Joshua Weiner1, Anju Duttargi1, Leonid Belyayev1, Chethan Ashokkumar2, Rakesh Sindhi2, Olga A Timofeeva3, Michael Zasloff1, Cal S Matsumoto1, Thomas M Fishbein1.   

Abstract

By presenting the first case report of true operational tolerance in an intestinal transplant patient, we aim to demonstrate that tolerance is possible in a field that has been hampered by suboptimal outcomes. Although operational tolerance has been achieved in liver and kidney transplantation, and some intestinal transplant patients have been able to decrease immunosuppression, this is the first instance of true operational tolerance after complete cessation of immunosuppression. A patient received a deceased-donor small intestinal and colon allograft with standard immunosuppressive treatment, achieving excellent graft function after overcoming a graft-versus-host-disease episode 5 months posttransplant. Four years later, against medical advice, the patient discontinued all immunosuppression. During follow-up visits 2 and 3 years after cessation of immunosuppression, the patient exhibited normal graft function with full enteral autonomy and without histological or endoscopic signs of rejection. Mechanistic analysis demonstrated immune competence against third party antigen, with in vitro evidence of donor-specific hyporesponsiveness in the absence of donor macrochimerism. This proof of principle case can stimulate future mechanistic studies on diagnostic and therapeutic strategies, for example, cellular therapy trials, that can lead to minimization or elimination of immunosuppression and, it is hoped, help revitalize the field of intestinal transplantation.
© 2020 The American Society of Transplantation and the American Society of Transplant Surgeons.

Entities:  

Keywords:  T cell biology; cellular biology; clinical research/practice; immune regulation; immunosuppression/immune modulation; intestinal (allograft) function/dysfunction; intestine/multivisceral transplantation; mucosal immunity; tolerance; translational research/science

Mesh:

Substances:

Year:  2020        PMID: 32721092      PMCID: PMC8274367          DOI: 10.1111/ajt.16224

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  19 in total

1.  Tolerogenic immunosuppression for organ transplantation.

Authors:  Thomas E Starzl; Noriko Murase; Kareem Abu-Elmagd; Edward A Gray; Ron Shapiro; Bijan Eghtesad; Robert J Corry; Mark L Jordan; Paulo Fontes; Tim Gayowski; Geoffrey Bond; Velma P Scantlebury; Santosh Potdar; Parmjeet Randhawa; Tong Wu; Adriana Zeevi; Michael A Nalesnik; Jennifer Woodward; Amadeo Marcos; Massimo Trucco; Anthony J Demetris; John J Fung
Journal:  Lancet       Date:  2003-05-03       Impact factor: 79.321

Review 2.  Intestinal transplantation.

Authors:  Thomas M Fishbein
Journal:  N Engl J Med       Date:  2009-09-03       Impact factor: 91.245

Review 3.  Achieving operational tolerance in transplantation: how can lessons from the clinic inform research directions?

Authors:  Deepak Chandrasekharan; Fadi Issa; Kathryn J Wood
Journal:  Transpl Int       Date:  2013-03-21       Impact factor: 3.782

4.  Allospecific CD154 + T-cytotoxic memory cells as potential surrogate for rejection risk in pediatric intestine transplantation.

Authors:  Rakesh Sindhi; Chethan Ashokkumar; Brandon W Higgs; P B Gilbert; Qing Sun; Sarangarajan Ranganathan; Ron Jaffe; Sara Snyder; Mylarappa Ningappa; Kyle A Soltys; Geoffrey J Bond; George V Mazariegos; Kareem Abu-Elmagd; Adriana Zeevi
Journal:  Pediatr Transplant       Date:  2011-11-29

5.  Five-year histological and serological follow-up of operationally tolerant pediatric liver transplant recipients enrolled in WISP-R.

Authors:  Sandy Feng; Anthony J Demetris; Katharine M Spain; Sai Kanaparthi; Bryna E Burrell; Udeme D Ekong; Estella M Alonso; Philip Rosenthal; Laurence A Turka; David Ikle; Nadia K Tchao
Journal:  Hepatology       Date:  2016-07-27       Impact factor: 17.425

Review 6.  Clinical operational tolerance after renal transplantation: current status and future challenges.

Authors:  Giuseppe Orlando; Peiman Hematti; Robert J Stratta; George W Burke; Pierpaolo Di Cocco; Pierpaolo Di Cocco; Francesco Pisani; Shay Soker; Kathryn Wood
Journal:  Ann Surg       Date:  2010-12       Impact factor: 12.969

7.  A pilot study of operational tolerance with a regulatory T-cell-based cell therapy in living donor liver transplantation.

Authors:  Satoru Todo; Kenichiro Yamashita; Ryoichi Goto; Masaaki Zaitsu; Akihisa Nagatsu; Tetsu Oura; Masaaki Watanabe; Takeshi Aoyagi; Tomomi Suzuki; Tsuyoshi Shimamura; Toshiya Kamiyama; Norihiro Sato; Junichi Sugita; Kanako Hatanaka; Hisashi Bashuda; Sonoko Habu; Anthony J Demetris; Ko Okumura
Journal:  Hepatology       Date:  2016-03-10       Impact factor: 17.425

Review 8.  Operational tolerance after liver transplantation.

Authors:  Giuseppe Orlando; Shay Soker; Kathryn Wood
Journal:  J Hepatol       Date:  2009-03-27       Impact factor: 25.083

9.  Enhanced B Cell Alloantigen Presentation and Its Epigenetic Dysregulation in Liver Transplant Rejection.

Authors:  M Ningappa; C Ashokkumar; B W Higgs; Q Sun; R Jaffe; G Mazariegos; D Li; D E Weeks; S Subramaniam; R Ferrell; H Hakonarson; R Sindhi
Journal:  Am J Transplant       Date:  2015-12-11       Impact factor: 8.086

10.  Macrochimerism in Intestinal Transplantation: Association With Lower Rejection Rates and Multivisceral Transplants, Without GVHD.

Authors:  J Zuber; S Rosen; B Shonts; B Sprangers; T M Savage; S Richman; S Yang; S P Lau; S DeWolf; D Farber; G Vlad; E Zorn; W Wong; J Emond; B Levin; M Martinez; T Kato; M Sykes
Journal:  Am J Transplant       Date:  2015-05-18       Impact factor: 8.086

View more
  1 in total

Review 1.  Update on immunosuppressive strategies in intestinal transplantation.

Authors:  Jonathan Merola; Abrar Shamim; Joshua Weiner
Journal:  Curr Opin Organ Transplant       Date:  2022-04-01       Impact factor: 2.640

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.